Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine chemodenervation of vastus intermedius and rectus femoris for post-stroke stiff-knee gait
NL-OMON48620Recruiting
- Sponsor
- Roessingh
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of lidocaine in stroke and hemiplegia, sponsored by Roessingh. Primary endpoint: Knee flexion during gait. Started Oct 2019; status: recruiting.
02
Drugs
lidocaine
03
Conditions
strokehemiplegia
Beyond the preview
Go deeper on NL-OMON48620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON48620.